Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Declines By 73.6%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large decrease in short interest in June. As of June 30th, there was short interest totaling 3,425 shares, a decrease of 73.6% from the June 15th total of 12,988 shares. Currently, 2.3% of the company’s shares are sold short. Based on an average daily trading volume, of 4,287 shares, the short-interest ratio is presently 0.8 days.

iShares Neuroscience and Healthcare ETF Trading Down 1.3%

NYSEARCA IBRN traded down $0.49 during trading hours on Tuesday, hitting $37.72. The company’s stock had a trading volume of 6,055 shares, compared to its average volume of 2,176. The company has a market capitalization of $5.66 million, a PE ratio of 15.61 and a beta of 0.73. iShares Neuroscience and Healthcare ETF has a 52 week low of $22.41 and a 52 week high of $40.42. The company’s 50-day simple moving average is $36.15 and its two-hundred day simple moving average is $33.84.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.